Glen Anthony Gole

Prof. Glen Anthony Gole

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
TCTailoi Chan-Ling
Tailoi Chan-Ling
GGGlen Anthony Gole
Glen Anthony Gole
GQGraham E. Quinn
Graham E. Quinn
SASamuel J. Adamson
Samuel J. Adamson
BDBrian A Darlow
Brian A Darlow

2 March 2009 in European Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
RHRobert F. Hess
Robert F. Hess
Benjamin ThompsonBenjamin Thompson
Benjamin Thompson
GGGlen Gole
Glen Gole
KMKathy T. Mullen
Kathy T. Mullen
Amblyopia or lazy eye is the most common cause of uniocular blindness in adults. It is caused by a disruption to normal visual development as a consequence of unmatched inputs from the two eyes in early life, arising from a turned eye (strabismus), unequal refractive error (anisometropia) or form deprivation (e.g. cataract). Animal models based on extracellular recordings in anesthetized animals suggest that the earliest site of the anomaly in the primate visual pathway is the primary visual cortex (corresponding to the striate cortex, cytoarchitectonic area 17 and area V1), which is where inputs from the two eyes are first combined in an excitatory fashion, whereas more distal and monocular processing structures such as the retina and lateral geniculate nucleus (LGN) are normal. Using high‐field functional magnetic resonance imaging in a group of human adults with amblyopia, we demonstrate that functional deficits are first observable at a thalamic level, that of the LGN. Our results suggest the need to re‐evaluate the current models of amblyopia that are based on the assumption of a purely cortical dysfunction, as well as the role for the LGN in visual development.

19 April 2006 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
ASAndrew Re Smith
Andrew Re Smith
SOStephen B O'Hagan
Stephen B O'Hagan
GGGlen Anthony Gole
Glen Anthony Gole

2 November 2011 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Open access
PDF file
DGDavid J Gunn
David J Gunn
DCDavid W Cartwright
David W Cartwright
GGGlen Anthony Gole
Glen Anthony Gole
Background:  To report the incidence of retinopathy of prematurity (ROP) in a subgroup of extremely premature infants admitted to an Australian tertiary centre over an 18‐year period.Design:  Retrospective study. Royal Brisbane and Women's Hospital Neonatal Intensive Care Unit.Participants:  Five hundred and fifty‐four infants admitted between 23 and 25.6 weeks gestational age (GA).Methods:  The 18‐year study was divided into three 6‐year periods for analysis: period 1 (1992–1997), period 2 (1998–2003) and period 3 (2004–2009). Infants were compared based on their week of GA and by the study period in which they were born.Main Outcome Measures:  GA, birthweight, incidence and severity of ROP.Results:  Three hundred seventy‐three (67.3%) infants survived until ROP screening, and 351 (63.4%) survived until discharge. ROP incidence increased from 78.2% in period 1 to 86.1% in period 3. Over the entire study, 90.5% of 23‐week GA infants had ROP compared with 89.7% of 24‐week GA infants and 76.1% of 25‐week GA infants. Mean birthweight was significantly lower in infants with any ROP (725.1 g) and ROP of at least stage 3 (720.8 g) compared with infants without ROP (806.5 g) (P < 0.0001). Twenty‐three–week GA infants had more severe ROP (28.6%) than 24 weeks (18.3%) and 25 weeks GA (11.9%).Conclusions:  There has been increased survival and incidence of ROP in extremely premature infants over the past 20 years. Lower birthweight and GA are both associated with higher incidence and more severe ROP.

27 November 2003 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
MFMichael P Forrest
Michael P Forrest
SFSidney Finnigan
Sidney Finnigan
SFSonya Finnigan
Sonya Finnigan
GGGlen Anthony Gole
Glen Anthony Gole

23 January 2014 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
DGDavid J Gunn
David J Gunn
DCDavid W Cartwright
David W Cartwright
GGGlen Anthony Gole
Glen Anthony Gole